Annual Net Income
-$528.63 M
+$123.54 M+18.94%
31 December 2023
Summary:
Apellis Pharmaceuticals annual net profit is currently -$528.63 million, with the most recent change of +$123.54 million (+18.94%) on 31 December 2023. During the last 3 years, it has fallen by -$183.75 million (-53.28%). APLS annual net income is now -13243.80% below its all-time high of -$3.96 million, reached on 31 December 2013.APLS Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Net Income
-$57.45 M
-$19.79 M-52.55%
30 September 2024
Summary:
Apellis Pharmaceuticals quarterly net profit is currently -$57.45 million, with the most recent change of -$19.79 million (-52.55%) on 30 September 2024. Over the past year, it has increased by +$82.79 million (+59.04%). APLS quarterly net income is now -173.40% below its all-time high of $78.27 million, reached on 31 December 2020.APLS Quarterly Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM Net Income
-$250.10 M
+$82.79 M+24.87%
30 September 2024
Summary:
Apellis Pharmaceuticals TTM net profit is currently -$250.10 million, with the most recent change of +$82.79 million (+24.87%) on 30 September 2024. Over the past year, it has increased by +$355.94 million (+58.73%). APLS TTM net income is now -10025.55% below its all-time high of -$2.47 million, reached on 30 September 2014.APLS TTM Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
APLS Net Income Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +18.9% | +59.0% | +58.7% |
| 3 y3 years | -53.3% | +70.6% | +51.9% |
| 5 y5 years | -314.6% | +17.7% | -9.5% |
APLS Net Income High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -53.3% | +29.2% | -52.5% | +70.6% | at high | +66.5% |
| 5 y | 5 years | -314.6% | +29.2% | -173.4% | +73.8% | -9.5% | +66.5% |
| alltime | all time | <-9999.0% | +29.2% | -173.4% | +73.8% | <-9999.0% | +66.5% |
Apellis Pharmaceuticals Net Income History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$57.45 M(+52.5%) | -$250.10 M(-24.9%) |
| June 2024 | - | -$37.66 M(-43.3%) | -$332.89 M(-20.2%) |
| Mar 2024 | - | -$66.42 M(-25.0%) | -$417.27 M(-21.1%) |
| Dec 2023 | -$528.63 M(-18.9%) | -$88.58 M(-36.8%) | -$528.63 M(-12.8%) |
| Sept 2023 | - | -$140.24 M(+14.9%) | -$606.04 M(-7.8%) |
| June 2023 | - | -$122.04 M(-31.4%) | -$657.08 M(-4.9%) |
| Mar 2023 | - | -$177.78 M(+7.1%) | -$691.01 M(+6.0%) |
| Dec 2022 | -$652.17 M(-12.6%) | -$165.99 M(-13.2%) | -$652.17 M(+2.8%) |
| Sept 2022 | - | -$191.27 M(+22.6%) | -$634.11 M(-0.7%) |
| June 2022 | - | -$155.98 M(+12.3%) | -$638.42 M(-9.0%) |
| Mar 2022 | - | -$138.94 M(-6.1%) | -$701.63 M(-6.0%) |
| Dec 2021 | -$746.35 M(+116.4%) | -$147.93 M(-24.4%) | -$746.35 M(+43.5%) |
| Sept 2021 | - | -$195.57 M(-10.8%) | -$520.16 M(+13.0%) |
| June 2021 | - | -$219.19 M(+19.3%) | -$460.29 M(+28.0%) |
| Mar 2021 | - | -$183.66 M(-334.7%) | -$359.71 M(+4.3%) |
| Dec 2020 | -$344.87 M(+13.2%) | $78.27 M(-157.7%) | -$344.87 M(-35.7%) |
| Sept 2020 | - | -$135.70 M(+14.4%) | -$536.36 M(+14.0%) |
| June 2020 | - | -$118.62 M(-29.7%) | -$470.48 M(+11.2%) |
| Mar 2020 | - | -$168.82 M(+49.1%) | -$422.95 M(+38.8%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2019 | -$304.71 M(+139.0%) | -$113.22 M(+62.1%) | -$304.71 M(+33.4%) |
| Sept 2019 | - | -$69.83 M(-1.8%) | -$228.37 M(+17.7%) |
| June 2019 | - | -$71.09 M(+40.6%) | -$194.10 M(+24.1%) |
| Mar 2019 | - | -$50.57 M(+37.1%) | -$156.34 M(+22.6%) |
| Dec 2018 | -$127.50 M(+150.0%) | -$36.89 M(+3.8%) | -$127.50 M(+17.1%) |
| Sept 2018 | - | -$35.55 M(+6.6%) | -$108.87 M(+28.2%) |
| June 2018 | - | -$33.33 M(+53.4%) | -$84.90 M(+33.3%) |
| Mar 2018 | - | -$21.74 M(+19.1%) | -$63.69 M(+24.9%) |
| Dec 2017 | -$51.01 M(+88.0%) | -$18.26 M(+57.7%) | -$51.01 M(+29.6%) |
| Sept 2017 | - | -$11.57 M(-4.6%) | -$39.37 M(+12.5%) |
| June 2017 | - | -$12.13 M(+34.0%) | -$35.01 M(+53.0%) |
| Mar 2017 | - | -$9.05 M(+36.7%) | -$22.88 M(+65.4%) |
| Dec 2016 | -$27.12 M(-41.7%) | -$6.62 M(-8.2%) | -$13.83 M(-10.3%) |
| Sept 2016 | - | -$7.21 M(-12.2%) | -$15.43 M(-60.9%) |
| Dec 2015 | -$46.52 M(+331.2%) | -$8.22 M(-73.7%) | -$39.41 M(+16.3%) |
| Sept 2015 | - | -$31.19 M(+1059.9%) | -$33.88 M(+556.7%) |
| Dec 2014 | -$10.79 M(+172.3%) | -$2.69 M(+8.9%) | -$5.16 M(+108.9%) |
| Sept 2014 | - | -$2.47 M | -$2.47 M |
| Dec 2013 | -$3.96 M | - | - |
FAQ
- What is Apellis Pharmaceuticals annual net profit?
- What is the all time high annual net income for Apellis Pharmaceuticals?
- What is Apellis Pharmaceuticals annual net income year-on-year change?
- What is Apellis Pharmaceuticals quarterly net profit?
- What is the all time high quarterly net income for Apellis Pharmaceuticals?
- What is Apellis Pharmaceuticals quarterly net income year-on-year change?
- What is Apellis Pharmaceuticals TTM net profit?
- What is the all time high TTM net income for Apellis Pharmaceuticals?
- What is Apellis Pharmaceuticals TTM net income year-on-year change?
What is Apellis Pharmaceuticals annual net profit?
The current annual net income of APLS is -$528.63 M
What is the all time high annual net income for Apellis Pharmaceuticals?
Apellis Pharmaceuticals all-time high annual net profit is -$3.96 M
What is Apellis Pharmaceuticals annual net income year-on-year change?
Over the past year, APLS annual net profit has changed by +$123.54 M (+18.94%)
What is Apellis Pharmaceuticals quarterly net profit?
The current quarterly net income of APLS is -$57.45 M
What is the all time high quarterly net income for Apellis Pharmaceuticals?
Apellis Pharmaceuticals all-time high quarterly net profit is $78.27 M
What is Apellis Pharmaceuticals quarterly net income year-on-year change?
Over the past year, APLS quarterly net profit has changed by +$82.79 M (+59.04%)
What is Apellis Pharmaceuticals TTM net profit?
The current TTM net income of APLS is -$250.10 M
What is the all time high TTM net income for Apellis Pharmaceuticals?
Apellis Pharmaceuticals all-time high TTM net profit is -$2.47 M
What is Apellis Pharmaceuticals TTM net income year-on-year change?
Over the past year, APLS TTM net profit has changed by +$355.94 M (+58.73%)